We modelled four interventions: increase in use of SGLT2is or GLP-1 RAs to 75% of the total population with type 2 diabetes, and increase in use of SGLT2is or GLP-1 RAs to 75% of the secondary prevention population (i.e
Molecular and cellular actions of a structural domain of human growth hormone (AOD9401) on lipid metabolism in Zucker fatty rats Journal of Molecular Endocrinology, 2000 Dec, Volume 25 (Issue 3), Pages 287-98
Like a relay race without a clear handoff, patients often move between providers, platforms, and pharmacies without consistent oversight
Key contraindications include pregnancy and breastfeeding, with caution advised in those with thyroid disease, pancreatitis history, or severe gastrointestinal disease
However, the increase in SMBG was minor (0.5 mmol/l), had reversed by approximately week 56 and, by the end of the trial, HbA 1c , FPG and SMBG had improved in both treatment groups, suggesting that there was no lasting impact on glycaemic outcomes